Johannes Bhakdi is the founder of Quantgene, a company established in 2014 that combines precision genomics, AI, and a new perspective on medicine to detect disease at early stages. He has galvanized a network of scientists and engineers to address computational and clinical challenges in DNA sequencing, aiming to advance the future of medicine.

In addition to his work at Quantgene, Bhakdi is the Founder & CEO of i2X Capital, a role he has held since 2011.